Oncogenes in cancer cells or genetic mutations in the HMOX1 promotor, the gene encoding HO-1, can drive the constitutive expression of HO-1, leading to potent immunomodulating anti-tumor immune responses. The gene discussed is HMOX1; the disease is neoplasm.